A. Kaser, S. Zeissig, and R. S. Blumberg, Inflammatory bowel disease, Annu Rev Immunol, vol.28, pp.573-621, 2010.

K. Cadwell, Crohn's disease susceptibility gene interactions, a NOD to the newcomer ATG16L1, Gastroenterology, vol.139, pp.1448-1450, 2010.

B. Chassaing and A. Darfeuille-michaud, The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases, Gastroenterology, vol.140, pp.1720-1728, 2011.

R. B. Sartor, Microbial influences in inflammatory bowel diseases, Gastroenterology, vol.134, pp.577-594, 2008.

Y. K. Lee and S. K. Mazmanian, Has the microbiota played a critical role in the evolution of the adaptive immune system, Science, vol.330, pp.1768-1773, 2010.

E. Slack, S. Hapfelmeier, B. Stecher, Y. Velykoredko, and M. Stoel, Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism, Science, vol.325, pp.617-620, 2009.

S. Uematsu and K. Fujimoto, The innate immune system in the intestine, Microbiol Immunol, vol.54, pp.645-657, 2010.

O. Shibolet and D. K. Podolsky, TLRs in the Gut. IV. Negative regulation of Tolllike receptors and intestinal homeostasis: addition by subtraction, Am J Physiol Gastrointest Liver Physiol, vol.292, pp.1469-1473, 2007.

J. M. Wells, O. Rossi, M. Meijerink, and P. Van-baarlen, Epithelial crosstalk at the microbiota-mucosal interface, Proc Natl Acad Sci, vol.108, pp.4607-4614, 2011.

A. Mizoguchi and E. Mizoguchi, Animal models of IBD: linkage to human disease, Curr Opin Pharmacol, vol.10, pp.578-587, 2010.

K. S. Kobayashi, M. Chamaillard, Y. Ogura, O. Henegariu, and N. Inohara, Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract, Science, vol.307, pp.731-734, 2005.

C. Lupp, M. L. Robertson, M. E. Wickham, I. Sekirov, and O. L. Champion, Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae, Cell Host Microbe, vol.2, p.204, 2007.

S. E. Winter, P. Thiennimitr, M. G. Winter, B. P. Butler, and D. L. Huseby, Gut inflammation provides a respiratory electron acceptor for Salmonella, Nature, vol.467, pp.426-429, 2010.

C. P. Davis and D. C. Savage, Habitat, succession, attachment, and morphology of segmented, filamentous microbes indigenous to the murine gastrointestinal tract, Infect Immun, vol.10, pp.948-956, 1974.

H. L. Klaasen, J. P. Koopman, M. E. Van-den-brink, M. H. Bakker, and F. G. Poelma, Intestinal, segmented, filamentous bacteria in a wide range of vertebrate species, Lab Anim, vol.27, pp.141-150, 1993.

N. Cerf-bensussan and V. Gaboriau-routhiau, The immune system and the gut microbiota: friends or foes?, Nat Rev Immunol, vol.10, pp.735-744, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01204303

I. I. Ivanov, K. Atarashi, N. Manel, E. L. Brodie, and T. Shima, Induction of intestinal Th17 cells by segmented filamentous bacteria, Cell, vol.139, pp.485-498, 2009.

S. E. Erdman, V. P. Rao, T. Poutahidis, A. B. Rogers, and C. L. Taylor, Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice, Proc Natl Acad Sci, vol.106, pp.1027-1032, 2009.

J. Chow and S. K. Mazmanian, A pathobiont of the microbiota balances host colonization and intestinal inflammation, Cell Host Microbe, vol.7, pp.265-276, 2010.

W. Strober, I. Fuss, and P. Mannon, The fundamental basis of inflammatory bowel disease, J Clin Invest, vol.117, pp.514-521, 2007.

H. C. Rath, H. H. Herfarth, J. S. Ikeda, W. B. Grenther, and T. E. Hamm, Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats, J Clin Invest, vol.98, pp.945-953, 1996.

R. K. Sellon, S. Tonkonogy, M. Schultz, L. A. Dieleman, and W. Grenther, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice, Infect Immun, vol.66, pp.5224-5231, 1998.

J. D. Taurog, J. A. Richardson, J. T. Croft, W. A. Simmons, and M. Zhou, The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats, J Exp Med, vol.180, pp.2359-2364, 1994.

C. Veltkamp, S. L. Tonkonogy, D. Jong, Y. P. Albright, C. Grenther et al., Importance of Bacteria as Trigger in Inflammatory Bowel Disease, J Gastroint Dig Syst, vol.8, p.3, 2012.

J. F. Colombel, G. Vernier-massouille, A. Cortot, C. Gower-rousseau, and J. L. Salomez, Epidemiology and risk factors of inflammatory bowel diseases, 2007.

, Bull Acad Natl Med, vol.191, pp.1105-1118

A. Darfeuille-michaud, C. Neut, N. Barnich, E. Lederman, D. Martino et al., Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease, Gastroenterology, vol.115, pp.1405-1413, 1998.

A. Darfeuille-michaud, J. Boudeau, P. Bulois, C. Neut, and A. L. Glasser, High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease, Gastroenterology, vol.127, pp.412-421, 2004.

H. M. Martin, B. J. Campbell, C. A. Hart, C. Mpofu, and M. Nayar, Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer, Gastroenterology, vol.127, pp.80-93, 2004.

M. Martinez-medina, X. Aldeguer, M. Lopez-siles, F. Gonzalez-huix, and C. Lopez-oliu, Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease, Inflamm Bowel Dis, vol.15, pp.872-882, 2009.

M. Baumgart, B. Dogan, M. Rishniw, G. Weitzman, and B. Bosworth, Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum, ISME J, vol.1, pp.403-418, 2007.

T. Eaves-pyles, C. A. Allen, J. Taormina, A. Swidsinski, and C. B. Tutt, Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells, Int J Med Microbiol, vol.298, pp.397-409, 2007.

M. Sasaki, S. V. Sitaraman, B. A. Babbin, P. Gerner-smidt, and E. M. Ribot, Invasive Escherichia coli are a feature of Crohn's disease, Lab Invest, vol.87, pp.1042-1054, 2007.

M. Martinez-medina, J. Garcia-gil, N. Barnich, L. H. Wieler, and C. Ewers, Adherent-invasive Escherichia coli phenotype displayed by intestinal pathogenic E. coli strains from cats, dogs, and swine, Appl Environ Microbiol, vol.77, pp.5813-5817, 2011.

K. W. Simpson, B. Dogan, M. Rishniw, R. E. Goldstein, and S. Klaessig, Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs, Infect Immun, vol.74, pp.4778-4792, 2006.

S. Mimouna, D. Goncalves, N. Barnich, A. Darfeuille-michaud, and P. Hofman, Crohn disease-associated Escherichia coli promote gastrointestinal inflammatory disorders by activation of HIF-dependent responses, Gut Microbes, vol.2, 2011.

B. Chassaing, N. Rolhion, A. De-vallee, S. Y. Salim, and M. Prorok-hamon, Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae, J Clin Invest, vol.121, pp.966-975, 2011.

E. Gullberg and J. D. Soderholm, Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease, Ann N Y Acad Sci, vol.1072, pp.218-232, 2006.

E. Wine, J. C. Ossa, S. D. Gray-owen, and P. M. Sherman, Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia, BMC Microbiol, vol.9, p.180, 2009.

J. Denizot, A. Sivignon, F. Barreau, C. Darcha, and H. F. Chan, Adherentinvasive Escherichia coli induce claudin-2 expression and barrier defect in CEABAC10 mice and crohn's disease patients, Inflamm Bowel Dis, vol.18, pp.294-304, 2011.

N. Barnich, J. Denizot, and A. Darfeuille-michaud, E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients, Pathol Biol, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02148411

S. Meconi, A. Vercellone, F. Levillain, B. Payre, A. Saati et al., Adherentinvasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro, Cell Microbiol, vol.9, pp.1252-1251, 2007.

A. L. Glasser, J. Boudeau, N. Barnich, M. H. Perruchot, and J. F. Colombel, Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death, Infect Immun, vol.69, pp.5529-5537, 2001.

M. A. Bringer, A. L. Glasser, C. H. Tung, S. Meresse, and A. Darfeuille-michaud, The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages, Cell Microbiol, vol.8, pp.471-484, 2006.

P. Lapaquette, A. L. Glasser, A. Huett, R. J. Xavier, and . Darfeuille-michaud, A Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly, Cell Microbiol, vol.12, pp.99-113, 2009.

F. A. Carvalho, N. Barnich, P. Sauvanet, C. Darcha, and A. Gelot, Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin, Inflamm Bowel Dis, vol.14, pp.1051-1060, 2008.

C. L. Sears, Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes, Clin Microbiol Rev, vol.22, pp.349-369, 2009.

T. P. Prindiville, R. A. Sheikh, S. H. Cohen, Y. J. Tang, and M. C. Cantrell, Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease, Emerg Infect Dis, vol.6, pp.171-174, 2000.

N. U. Toprak, A. Yagci, B. M. Gulluoglu, M. L. Akin, and P. Demirkalem, A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer, Clin Microbiol Infect, vol.12, pp.782-786, 2006.

L. W. Lamps, K. T. Madhusudhan, J. M. Havens, J. K. Greenson, and M. P. Bronner, Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease, Am J Surg Pathol, vol.27, pp.220-227, 2003.

R. R. Brubaker, Factors promoting cute and chronic diseases caused by yersiniae, Clin Microbiol Rev, vol.4, pp.309-324, 1991.

I. B. Autenrieth and R. Firsching, Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: an ultrastructural and histological study, J Med Microbiol, vol.44, pp.285-294, 1996.

M. A. Clark, B. H. Hirst, and M. A. Jepson, M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells, Infect Immun, vol.66, pp.1237-1243, 1998.

S. A. Handley, P. H. Dube, P. A. Revell, and V. L. Miller, Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice, Infect Immun, vol.72, pp.1645-1656, 2004.

M. J. Blaser, D. Hoverson, I. G. Ely, D. J. Duncan, and W. L. Wang, Studies of Campylobacter jejuni in patients with inflammatory bowel disease, Gastroenterology, vol.86, pp.33-38, 1984.

S. Taylor-robinson, R. Miles, A. Whitehead, and R. J. Dickinson, Salmonella infection and ulcerative colitis, Lancet, vol.1, p.1145, 1989.

K. Melby and S. Kildebo, Antibodies against Campylobacter jejuni/coli in patients suffering from campylobacteriosis or inflammatory bowel disease, NIPH Ann, vol.11, pp.47-52, 1988.

K. O. Gradel, H. L. Nielsen, H. C. Schonheyder, T. Ejlertsen, and B. Kristensen, Increased short-and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis, Gastroenterology, vol.137, pp.495-501, 2009.

B. Stecher, M. Barthel, M. C. Schlumberger, L. Haberli, and W. Rabsch, Motility allows S. Typhimurium to benefit from the mucosal defence, Cell Microbiol, vol.10, pp.1166-1180, 2008.

J. P. Hugot, C. Alberti, D. Berrebi, E. Bingen, and J. P. Cezard, Crohn's disease: the cold chain hypothesis, Lancet, vol.362, pp.2012-2015, 2003.

K. Gebauer, J. C. Hall, J. B. Donlon, R. Herrmann, and S. Rofe, Hepatic involvement in listeriosis, Aust N Z J Med, vol.19, pp.486-487, 1989.

T. T. Macdonald and P. B. Carter, Cell-mediated immunity to intestinal infection, Infect Immun, vol.28, pp.516-523, 1980.

R. R. Rickert and H. W. Carter, The "early" ulcerative lesion of Crohn's disease: correlative light-and scanning electron-microscopic studies, J Clin Gastroenterol, vol.2, pp.11-19, 1980.

P. Rutgeerts, K. Goboes, M. Peeters, M. Hiele, and F. Penninckx, Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum, Lancet, vol.338, pp.771-774, 1991.

A. Franke, D. P. Mcgovern, J. C. Barrett, K. Wang, and G. L. Radford-smith, Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci, Nat Genet, vol.42, pp.1118-1125, 2010.

R. Cooney, J. Baker, O. Brain, B. Danis, and T. Pichulik, NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation, Nat Med, vol.16, pp.90-97, 2010.

L. H. Travassos, L. A. Carneiro, M. Ramjeet, S. Hussey, and Y. G. Kim, Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry, Nat Immunol, vol.11, pp.55-62, 2010.

D. J. Klionsky, Crohn's disease, autophagy, and the Paneth cell, N Engl J Med, vol.360, pp.1785-1786, 2009.

T. Hisamatsu, M. Suzuki, H. C. Reinecker, W. J. Nadeau, and B. A. Mccormick, CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells, Gastroenterology, vol.124, pp.993-1000, 2003.

B. Opitz, A. Puschel, B. Schmeck, A. C. Hocke, and S. Rosseau, Nucleotidebinding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae, J Biol Chem, vol.279, pp.36426-36432, 2004.

U. Meinzer, S. Esmiol-welterlin, F. Barreau, D. Berrebi, and M. Dussaillant, Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice, PLoS ONE, vol.3, p.2769, 2008.

J. Wehkamp, J. Harder, M. Weichenthal, M. Schwab, and E. Schaffeler, NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression, Gut, vol.53, pp.1658-1664, 2004.

L. A. Simms, J. D. Doecke, M. D. Walsh, N. Huang, and E. V. Fowler, Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease, Gut, vol.57, pp.903-910, 2008.

T. Petnicki-ocwieja, T. Hrncir, Y. J. Liu, A. Biswas, and T. Hudcovic, Nod2 is required for the regulation of commensal microbiota in the intestine, Proc Natl Acad Sci U S A, vol.106, pp.15813-15818, 2009.

P. Brest, P. Lapaquette, M. Souidi, K. Lebrigand, and A. Cesaro, A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease, Nat Genet, vol.43, pp.242-245, 2011.

K. Cadwell, J. Y. Liu, S. L. Brown, H. Miyoshi, and J. Loh, A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells, Nature, vol.456, pp.259-263, 2008.

K. Cadwell, K. K. Patel, N. S. Maloney, T. C. Liu, and A. C. Ng, Virus-plussusceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine, Cell, vol.141, pp.1135-1145, 2010.

M. M. Barmada, S. R. Brant, D. L. Nicolae, J. P. Achkar, and C. I. Panhuysen, A genome scan in 260 inflammatory bowel disease-affected relative pairs, Inflamm Bowel Dis, vol.10, pp.513-520, 2004.

S. Vermeire, P. Rutgeerts, K. Van-steen, S. Joossens, and G. Claessens, Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis, Gut, vol.53, pp.980-986, 2004.

A. Kaser, A. H. Lee, A. Franke, J. N. Glickman, and S. Zeissig, XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease, Cell, vol.134, pp.743-756, 2008.

N. Rolhion, N. Barnich, M. A. Bringer, A. L. Glasser, and J. Ranc, Abnormally expressed ER stress response chaperone Gp96 in CD favours adherentinvasive Escherichia coli invasion, Gut, vol.59, pp.1355-1362, 2010.
DOI : 10.1136/gut.2010.207456

URL : https://hal.archives-ouvertes.fr/hal-01218270

N. Barnich, F. A. Carvalho, A. L. Glasser, C. Darcha, and P. Jantscheff, CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease, J Clin Invest, vol.117, pp.1566-1574, 2007.
DOI : 10.1172/jci30504

URL : http://www.jci.org/articles/view/30504/files/pdf

F. A. Carvalho, N. Barnich, A. Sivignon, C. Darcha, and C. H. Chan, Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM, J Exp Med, vol.206, pp.2179-2189, 2009.
DOI : 10.1084/jem.20090741

URL : http://jem.rupress.org/content/206/10/2179.full.pdf

C. Abraham and J. H. Cho, Inflammatory bowel disease, N Engl J Med, vol.361, pp.2066-2078, 2009.

J. Glas, J. Seiderer, C. Fries, C. Tillack, and S. Pfennig, CEACAM6 gene variants in inflammatory bowel disease, PLoS One, vol.6, p.19319, 2011.
DOI : 10.1055/s-0030-1263683

URL : https://dash.harvard.edu/bitstream/1/5130452/1/3084820.pdf

R. B. Sartor, Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics, Gastroenterology, vol.126, pp.1620-1633, 2004.

D. Damaskos and G. Kolios, Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope', Br J Clin Pharmacol, vol.65, pp.453-467, 2008.
DOI : 10.1111/j.1365-2125.2008.03096.x

URL : https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2125.2008.03096.x

K. Isaacs and H. Herfarth, Role of probiotic therapy in IBD, Inflamm Bowel Dis, vol.14, pp.1597-1605, 2008.

A. W. Dupont and H. L. Dupont, The intestinal microbiota and chronic disorders of the gut, Nat Rev Gastroenterol Hepatol, vol.8, pp.523-531, 2011.

C. Huebner, Y. Ding, I. Petermann, C. Knapp, and L. R. Ferguson, The probiotic Escherichia coli Nissle 1917 reduces pathogen invasion and modulates cytokine expression in Caco-2 cells infected with Crohn's disease-associated E. coli LF82, Appl Environ Microbiol, vol.77, pp.2541-2544, 2011.

M. Schlee, J. Harder, B. Koten, E. F. Stange, and J. Wehkamp, Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2, Clin Exp Immunol, vol.151, pp.528-535, 2008.
DOI : 10.1111/j.1365-2249.2007.03587.x

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2249.2007.03587.x

M. Schlee, J. Wehkamp, A. Altenhoefer, T. A. Oelschlaeger, and E. F. Stange, Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin, Infect Immun, vol.75, pp.2399-2407, 2007.

R. M. Patel, L. S. Myers, A. R. Kurundkar, A. Maheshwari, and A. Nusrat, Importance of Bacteria as Trigger in Inflammatory Bowel Disease, J Gastroint Dig Syst, vol.8, p.3, 2012.

, JGDS, an open access journal Inflammatory Bowel Disease Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function, J Gastroint Dig Syst, vol.180, pp.626-635

K. A. Donato, M. G. Gareau, Y. J. Wang, and P. M. Sherman, Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling, Microbiology, vol.156, pp.3288-3297, 2010.
DOI : 10.1099/mic.0.040139-0

URL : http://mic.microbiologyresearch.org/deliver/fulltext/micro/156/11/3288.pdf?itemId=/content/journal/micro/10.1099/mic.0.040139-0&mimeType=pdf&isFastTrackArticle=

S. Hummel, K. Veltman, C. Cichon, U. Sonnenborn, and M. A. Schmidt, Differential Targeting of the E-Cadherin/beta-Catenin Complex by GramPositive Probiotic Lactobacilli Improves Epithelial Barrier Function, Appl Environ Microbiol, vol.78, pp.1140-1147, 2010.

M. Llopis, M. Antolin, M. Carol, N. Borruel, and F. Casellas, Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa, Inflamm Bowel Dis, vol.15, pp.275-283, 2009.
DOI : 10.1002/ibd.20736

M. Guslandi, P. Giollo, and P. A. Testoni, A pilot trial of Saccharomyces boulardii in ulcerative colitis, Eur J Gastroenterol Hepatol, vol.15, pp.697-698, 2003.

X. Wu, B. A. Vallance, L. Boyer, K. S. Bergstrom, and J. Walker, Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors, Am J Physiol Gastrointest Liver Physiol, vol.294, pp.295-306, 2008.
DOI : 10.1152/ajpgi.00173.2007

H. S. Lee, S. Y. Han, E. A. Bae, C. S. Huh, and Y. T. Ahn, Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice, Int Immunopharmacol, vol.8, pp.574-580, 2008.
DOI : 10.1016/j.intimp.2008.01.009

P. M. Sherman, J. C. Ossa, J. , and K. , Unraveling mechanisms of action of probiotics, Nutr Clin Pract, vol.24, pp.10-14, 2009.

, This article was originally published in a special issue, Inflammatory Bowel Disease handled by Editor(s). Dr. Jesús K. Yamamoto-Furusho